Skip to main content

Bruker s Organic Q4 Revenues Dip Slightly Though Loss Turns to Profit

NEW YORK, Feb. 23 (GenomeWeb News) - Bruker BioSciences yesterday reported fourth quarter 2005 revenues of $80.6 million, down from $85.6 million in the fourth quarter of 2004.


Revenues increased by 1 percent when adjusted for foreign currency effects, the company said.


Bruker reported net income of $1.9 million for the period ended Dec. 31, compared to a loss of $900,000 in the year-ago period.


R&D expenses dropped to $9.4 million in the current quarter, versus $12.1 million in the similar quarter last year.


The company had around $99.7 million in cash and short-term investments as of Dec. 31.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.